Molecular profiling in contemporary breast cancer management
Open Access
- 8 February 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (7) , 743-745
Abstract
Surgery remains the cornerstone of achieving breast cancer control, but understanding the biological and molecular processes that drive breast cancer development, coupled with the recent advances in therapeutic strategies, have facilitated an individualised approach to disease management. Even in the setting of hereditary breast cancer, risk-reducing surgery and novel targeted therapies have revolutionised management, with this being translated into enhanced oncological outcomes for the majority, including those with advanced disease. The rapidly evolving landscape of breast cancer management makes it imperative that breast surgeons’ knowledge of the biological disease spectrum aligns with contemporary practice. The aim of this review is to provide an update on how molecular cancer profiling influences the management of patients with primary breast cancer.Keywords
This publication has 28 references indexed in Scilit:
- Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 MutationJournal of Clinical Oncology, 2015
- Familial breast cancer: summary of updated NICE guidanceBMJ, 2013
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI: Journal of the National Cancer Institute, 2013
- BRCA in breast cancer: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2011
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Molecular portraits of human breast tumoursNature, 2000
- Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1995